Don't get too excited.
I don't know where she got those figures from.
The readout in September is for 90 patients assuming 45 treated with placebo and 45 treated with Rem-L.
So if those numbers she read out were true then it would possibly be because we have hit ~60% mark to date i.e. 180 patients in which case 90 patients have been dosed with Rem-L.
However, I doubt it, because that would be the scoop of the century.
I suggest waiting till the readout in early September, which is effectively two weeks away. Not long now!
GLTAB
HODL
Cell Therapy News/Articles, page-5693
-
- There are more pages in this discussion • 12,736 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |